Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Debt Ratio for 12 consecutive years, with 1.47 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 34.27% to 1.47 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.47 through Dec 2025, up 34.27% year-over-year, with the annual reading at 1.47 for FY2025, 34.27% up from the prior year.
  • Debt Ratio hit 1.47 in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from 1.48 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.7 in Q2 2025 to a low of 0.1 in Q4 2021.
  • Historically, Debt Ratio has averaged 0.91 across 5 years, with a median of 1.06 in 2023.
  • Biggest five-year swings in Debt Ratio: rose 2.64% in 2024 and later surged 58.61% in 2025.
  • Year by year, Debt Ratio stood at 0.1 in 2021, then rose by 7.33% to 0.11 in 2022, then skyrocketed by 852.8% to 1.06 in 2023, then increased by 3.46% to 1.1 in 2024, then surged by 34.27% to 1.47 in 2025.
  • Business Quant data shows Debt Ratio for IRWD at 1.47 in Q4 2025, 1.48 in Q3 2025, and 1.7 in Q2 2025.